Matt Newbold

Investment Director

Lloyds TSB Development Capital Ltd.

Joined: 2012

Office Phone:

+44 (0)115 947 1280

Direct Phone:

+44 (0)121 237 6500


  Pro - Try 1 Week Free
 

    and access,

  •     75K PE/M&A Contacts
  •     +
  •     4.6K PE Firms
  •     3.6K M&A Advisors
  •     194K Transactions
  •     198K Companies

  •     Market Services
  •     Build Lists
  •     Research Sectors
  •     Uncover Opportunities

Bio

Matt works closely with management teams across the Midlands looking to grow their business and is responsible for identifying ambitious teams that would benefit from the support of a private equity partner. Since joining LDC in 2012, Matt has invested more than £220million across ten high-profile businesses in the Midlands, including Kingswood ,The NEC Group, Prism Medical, Stuart Turner, Eley, SMH Fleet and CitySprint. Matt is currently Investor Director on the Boards of Stuart Turner and Biozone and sits on the UK & European Capital Committee for the BVCA which represents the interests of the BVCA’s mid-market members. After graduating from Nottingham Trent University with a First Class Degree in Accounting & Finance and qualifying as a Chartered Accountant, Matt gained eight years of corporate finance experience with PwC and Alantra (Catalyst Corporate Finance), working in the UK and North America.

Education

Work History

PwC Corporate Finance LLC

Catalyst Corporate Finance